Sickle Cell Disease (SCD) Treatment & Management: Approach Considerations, Hydroxyurea Therapy, Transfusion
What Is Persistent Pulmonary Hypertension Of The Newborn (PPHN)?
Persistent pulmonary hypertension of the newborn (PPHN) is a circulatory condition that occurs soon after birth. It happens to new babies whose lung vessels aren't open wide enough and have difficulty breathing once they've left the womb.
What is persistent pulmonary hypertension of the newborn? In short, PPHN is a serious breathing problem that affects very young babies. It usually affects babies born at full term or at 34 weeks or later. The lungs develop during this part of pregnancy, so it's common for babies with PPHN to have other breathing conditions too. PPHN is also known as persistent pulmonary hypertension in the newborn and persistent fetal circulation syndrome.
While in the womb, a baby receives oxygen from its mother and the placenta. Blood vessels in the baby's lungs are almost completely closed, so not much blood actually makes it to the lungs. Those blood vessels will open more after the baby is born and starts to take breaths. Only then will blood be able to travel to the lungs to receive oxygen. When PPHN happens, though, blood vessels in a baby's lungs don't open up enough, limiting the amount of oxygen passed along to the baby's organs and brain.
In addition to the brain and body not receiving the oxygen they need, pressure starts to build in the lungs' blood vessels. This high blood pressure, also known as pulmonary hypertension, is harmful to the baby's lungs and heart.
Exact PPHN causes aren't known. It's possible that underdeveloped or incorrectly developed blood vessels in the lungs cause PPHN. Another possible cause is the blood vessels' inability to adjust to breathing air once the baby is born.
Although the causes of PPHN aren't clear, there are definite risk factors that increase the likelihood of developing this condition. These can include:
Symptoms of PPHN can be different in every newborn. Look out for any of the following:
Health care providers will be quick to diagnose PPHN once a baby is born. In addition to the standard checks done after birth, they may perform the following tests on a baby that might have PPHN:
When treating PPHN, a health care provider will try to raise blood oxygen levels, regulate blood pressure, and open the blood vessels in the lungs wider. They might try medicine, fluids, or oxygen:
Another treatment method is giving the baby nitric oxide. Nitric oxide helps the blood vessels in the baby's lungs expand.
Once the baby has received initial treatment for PPHN, their lungs could take weeks or months to fully recover. They should be protected from colds, the flu, and other illnesses to avoid making their condition worse. The better they're able to heal, the less likely it is they'll have persistent pulmonary hypertension of the newborn long-term effects.
When blood doesn't make it all the way to a baby's lungs, they can't swap oxygen for carbon dioxide. This happens even when receiving 100% oxygen. This is a serious issue because all of the baby's organs need a steady stream of blood rich in oxygen. If the organs don't get what they need, serious long-term damage can be done.
Stay in close contact with the baby's health care provider as they recover from PPHN. Trust your instincts as you care for your child, and reach out if you have serious concerns about your baby's health.
First Successful Treatment Of Severe Pulmonary Hypertension With Umbilical Cord Stem Cells
Just a moment...This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and HoldPress and hold the button
If you believe this is an error, please contact our support team.
167.71.87.121 : b571b573-9b94-44b9-8232-e0ff3911
Pulmonary Arterial Responses To Reactive Oxygen Species Are Altered In Newborn Piglets With Chronic Hypoxia-Induced Pulmonary Hypertension
Buetler TM, Krauskopf A, Ruegg UT 2004 Role of superoxide as a signaling molecule. News Physiol Sci 19: 120–123
Lambeth JD 2007 Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med 43: 332–347
Lyle AN, Griendling KK 2006 Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 21: 269–280
Rhee SG 2006 H2O2, a necessary evil for cell signalling. Science 312: 1882–1883
Thannickal VJ, Fanburg BL 2000 Reactive oxygen species in cell signalling. Am J Physiol Lung Cell Mol Physiol 279: L1005–L1028
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J 2007 Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44–84
Brennan LA, Steinhorn RH, Wedgwood S, Mata-Greenwood E, Roark EA, Russell JA, Black SM 2003 Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res 92: 683–691
Dennis KE, Aschner JL, Milatovic D, Schmidt JW, Aschner M, Kaplowitz MR, Zhang Y, Fike CD 2009 NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol 297: L596–L607
Fike CD, Slaughter JC, Kaplowitz MR, Zhang Y, Aschner JL 2008 Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 295: L881–L888
Fresquet F, Pourageaud F, Leblais V, Brandes RP, Savineau J-P, Marthan R, Muller B 2006 Role of reactive oxygen species and gp91 phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br J Pharmacol 148: 714–723
Jankov RP, Kantores C, Pan J, Belik J 2008 Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats. Am J Physiol Lung Cell Mol Physiol 294: L233–L245
Liu JQ, Zelko IN, Erbynn EM, Sham JS, Folz RJ 2006 Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91 phox). Am J Physiol Lung Cell Mol Physiol 290: L2–L10
Mittal M, Roth M, Konig P, Hofmann S, Dony E, Goyal P, Selbitz A-C, Schermuly RT, Ghofrani HA, Kwapiszewska G, Kummer W, Klepetko W, Hoda MA, Fink L, Hanze J, Seeger W, Grimminger F, Schmidt HH, Weissmann N 2007 Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res 101: 258–267
Sturrock A, Cahill B, Norman K, Huecksteadt TP, Hill K, Sanders K, Karwande SV, Stringham JC, Bull DA, Gleich M, Kennedy TP, Hoidal JR 2006 Transforming growth factor β-1 induces Nox4 NADPH oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 290: L661–L673
El-Benna J, Dang PM, Gougerot-Pocidalo M 2008 Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin Immunopathol 30: 279–289
Suzuki YJ, Forman HJ, Sevanian A 1997 Oxidants as stimulators of signal transduction. Free Radic Biol Med 22: 269–285
Lakshminrusimha S, Russell JA, Wedgwood S, Gugino SF, Kazzaz JA, Davis JM, Steinhorn RH 2006 Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med 174: 1370–1377
Boyer CS, Bannenberg GL, Neve EP, Ryrfeldt A, Moldeus P 1995 Evidence for the activation of the signal-responsive phospholipase A2 by exogenous hydrogen peroxide. Biochem Pharmacol 50: 753–761
Rao GN, Runge MS, Alexander RW 1995 Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells. Biochim Biophys Acta 1265: 67–72
Fike CD, Kaplowitz MR 1994 Effect of chronic hypoxia on pulmonary vascular pressures in isolated lungs of newborn pigs. J Appl Physiol 77: 2853–2862
Fike CD, Kaplowitz MR 1996 Chronic hypoxia alters nitric oxide-dependent pulmonary vascular responses in lungs of newborn pigs. J Appl Physiol 81: 2078–2087
Fike CD, Kaplowitz MR, Zhang Y, Pfister SL 2005 Cyclooxygenase-2 and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn pigs. J Appl Physiol 98: 1111–1118
Fike CD, Pfister SL, Kaplowitz MR, Madden JA 2002 Cyclooxygenase contracting factors and altered pulmonary vascular responses in chronically hypoxic newborn pigs. J Appl Physiol 92: 67–74
Campbell WB, Ojeda SR 1987 Measurement of prostaglandin by radioimmunoassay. Methods Enzymol 141: 323–341
Britigan BE, Pou S, Rosen GM, Lilleg DM, Buettner GR 1990 Hydroxyl radical is not a product of the reaction of xanthine oxidase and xanthine. J Biol Chem 265: 17533–17538
McCord JM, Fridovich I 1968 The reduction of cytochrome c by milk xanthine oxidase. J Biol Chem 243: 5753–5760
Ardanaz N, Pagano PJ 2006 Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med (Maywood) 231: 237–251
Burghuber OC, Strife R, Zirolli J, Mathias MM, Murphy RC, Reeves JT, Voelkel NF 1986 Hydrogen peroxide induced pulmonary vasoconstriction in isolated rat lungs is attenuated by U60,257, a leucotriene synthesis blocker. Wien Klin Wochenschr 98: 117–119
Burke TM, Wolin MS 1987 Hydrogen peroxide elicits pulmonary artery relaxation and guanylate cyclase activation. Am J Physiol 252: H721–H732
Burke-Wolin T, Abate CJ, Wolin MS, Gurtner GH 1991 Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3′,5′-cyclic monophosphate. Am J Physiol 261: L393–L398
Fujimoto S, Asano T, Sakai M, Sakurai K, Takagi D, Yoshimoto N, Itoh T 2001 Mechanisms of hydrogen peroxide-induced relaxation in rabbit mesenteric small artery. Eur J Pharmacol 412: 291–300
Gao YJ, Lee RM 2005 Hydrogen peroxide is an endothelium-dependent contracting factor in rat renal artery. Br J Pharmacol 146: 1061–1068
Jin N, Rhoades RA 1997 Activation of tyrosine kinases in H2O2-induced contraction in pulmonary artery. Am J Physiol 272: H2686–H2692
Jones RD, Morice AH 2000 Hydrogen peroxide—an intracellular signal in the pulmonary circulation: involvement in hypoxic pulmonary vasoconstriction. Pharmacol Ther 88: 153–161
Lucchesi PA, Belmadani S, Matrougui K 2005 Hydrogen peroxide acts as both vasodilator and vasoconstrictor in the control of perfused mouse mesenteric resistance arteries. J Hypertens 23: 571–579
Sato A, Sakuma I, Gutterman DD 2003 Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol 285: H2345–H2354
Seeger W, Suttorp N, Schmidt F, Neuhof H 1986 The glutathione redox cycle as a defense system against hydrogen-peroxide-induced prostanoid formation and vasoconstriction in rabbit lungs. Am Rev Respir Dis 133: 1029–1036
Sheehan DW, Giese EC, Gugino SF, Russell JA 1993 Characterization and mechanisms of H2O2-induced contractions of pulmonary arteries. Am J Physiol 264: H1542–H1547
Yang ZW, Zheng T, Zhang A, Altura BT, Altura BM 1998 Mechanisms of hydrogen peroxide-induced contraction of rat aorta. Eur J Pharmacol 344: 169–181
Auch-Schwelk W, Katusic ZS, Vanhoutte PM 1989 Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 13: 859–864
Erdei N, Bagi Z, Edes I, Kaley G, Koller A 2007 H2O2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in Type 2 diabetic mice. Am J Physiol Heart Circ Physiol 292: H649–H656
García-Redondo AB, Briones AM, Beltrán AE, Alonso MJ, Simonsen U, Salaices M 2009 Hypertension increases contractile responses to hydrogen peroxide in resistance arteries through increased thromboxane A2, Ca2+, and superoxide anion levels. J Pharmacol Exp Ther 328: 19–27
Hibino M, Okumura K, Iwama Y, Mokuno S, Osanai H, Matsui H, Toki Y, Ito T 1999 Oxygen-derived free radical-induced vasoconstriction by thromboxane A2 in aorta of the spontaneously hypertensive rat. J Cardiovasc Pharmacol 33: 605–610
Rodríquez-Martínez MA, García-Cohen EC, Baena AB, González R, Salaíces M, Marín J 1998 Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol 125: 1329–1335
Gao YJ, Lee RM 2001 Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A2 production. Br J Pharmacol 134: 1639–1646
Leffler CW, Busija DW, Armstead WM, Mirro R 1990 H2O2 effects on cerebral prostanoids and pial arteriolar diameter in piglets. Am J Physiol 258: H1382–H1387
Sanderud J, Norstein J, Saugstad OD 1991 Reactive oxygen metabolites produce pulmonary vasoconstriction in young pigs. Pediatr Res 29: 543–547
Tate RM, Morris HG, Schroeder WR, Repine JE 1984 Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. J Clin Invest 74: 608–613
Thengchaisri N, Kuo L 2003 Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. Am J Physiol Heart Circ Physiol 285: H2255–H2263
Yamaguchi K, Asano K, Mori M, Takasugi T, Fujita H, Suzuki Y, Kawashiro T 1994 Constriction and dilatation of pulmonary arterial ring by hydrogen peroxide-importance of prostanoids. Adv Exp Med Biol 361: 457–463
Rhoades RA, Packer CS, Roepke DA, Jin N, Meiss RA 1990 Reactive oxygen species alter contractile properties of pulmonary arterial smooth muscle. Can J Physiol Pharmacol 68: 1581–1589
Gong Y, Yi M, Fediuk J, Lizotte PP, Dakshinamurti S 2010 Hypoxic neonatal pulmonary arterial myocytes are sensitized to ROS-generated 8-isoprostane. Free Radic Biol Med 48: 882–894
Sanderud J, Bjoro K, Saugstad OD 1993 Oxygen radicals stimulate thromboxane and prostacyclin synthesis and induce vasoconstriction in pig lungs. Scand J Clin Lab Invest 53: 447–455
Fike CD, Kaplowitz MR, Zhang Y, Madden JA 2006 Voltage-gated K+ channels at an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol 291: L1169–L1176
Waypa GB, Schumacker PT 2005 Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J Appl Physiol 98: 404–414
Forman HJ 2007 Use and abuse of exogenous H2O2 in studies of signal transduction. Free Radic Biol Med 42: 926–932
Reth M 2002 Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 3: 1129–1134
Comments
Post a Comment